Wellmaker Bio is a spin-off company from Seoul Asan Medical Centre (AMC), which is the largest and most renowned hospital in the Republic of Korea. We specialize in developing predictive biomarkets and first-in-class drugs through profound research know-hows and clinical information from AMC. We strive to bring a better outcome to patients and contribute to the healthy life of a mankind through 'New Drug Development Research Institute' that is comprised of bio-research center, medicinal chemistry research center, cmc center and clinical development center.
See more: http://www.wmbio.co/en/about/company.php
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.